← Evidence map

ArticleTherapeutic advances in medical oncology2026

Prognostic impact of baseline blood biomarkers in SCLC first-line treatment.

Yibing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42205856